dc.contributor.author | Alazawi, W | en_US |
dc.contributor.author | Mathur, R | en_US |
dc.contributor.author | Abeysekera, K | en_US |
dc.contributor.author | Hull, S | en_US |
dc.contributor.author | Boomla, K | en_US |
dc.contributor.author | Robson, J | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.date.accessioned | 2015-03-25T14:45:51Z | |
dc.date.accessioned | 2016-01-19T17:15:38Z | |
dc.date.available | 2014-05-27 | en_US |
dc.date.issued | 2014-11 | en_US |
dc.identifier.issn | 0960-1643 | en_US |
dc.identifier.other | 10.3399/bjgp14X682273 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/10805 | |
dc.description.abstract | Liver disease is a major cause of morbidity and mortality worldwide. Large numbers of liver function tests (LFTs) are performed in primary care, with abnormal liver biochemistry a common finding. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. Metabolic syndrome, common in people from South Asia, is an important risk factor for NAFLD. | |
dc.format.extent | E694 - E702 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF GENERAL PRACTICE | en_US |
dc.relation.replaces | http://qmro.qmul.ac.uk/jspui/handle/123456789/7004 | |
dc.relation.replaces | 123456789/7004 | |
dc.rights | This is an OpenAccess article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.subject | ethnicity | en_US |
dc.subject | liver | en_US |
dc.subject | liver disease | en_US |
dc.subject | NAFLD | en_US |
dc.subject | population | en_US |
dc.title | Ethnicity and the diagnosis gap in liver disease: a population-based study | en_US |
dc.type | Article | |
dc.rights.holder | © British Journal of General Practice 2014 | |
dc.identifier.doi | 10.3399/bjgp14X682273 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345854700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 628 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 64 | en_US |
dcterms.abstract | Liver disease is a major cause of morbidity and mortality worldwide. Large numbers of liver function tests (LFTs) are performed in primary care, with abnormal liver biochemistry a common finding. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. Metabolic syndrome, common in people from South Asia, is an important risk factor for NAFLD. | |